2020


​
2020 ASH Abstract Achievement Award
​Researcher: Stephen Chong, PhD
Title: Re-Wiring BCL-2 Family Anti-Apoptotic Protein Dependencies through Modulating Phosphorylation to Re-Sensitize Venetoclax-Resistant Lymphoid Malignancies to BCL-2 Inhibition

2019



2019 ASH Abstract Achievement Award
Researcher: Charles Herbaux, MD
Title: Characterizing the Anti-Apoptotic Dependencies of T-Cell Prolymphocytic Leukemia Identifies HDAC and JAK/STAT Pathway Inhibitors As Promising Combination Partners to Augment Bcl-2 Targeted Killing By Venetoclax

2018

Picture



​2018 James O. Armitage Clinical Investigator Award
Researcher: Matthew S. Davids, MD, MMSc
For more information on this award, click here.

2018 ASH Abstract Achievement Award
Researcher: Rebecca Valentin, MD
Title: The Fully Human Anti-CD47 Antibody SRF231 Has Dual-Mechanism Antitumor Activity Against Chronic Lymphocytic Leukemia (CLL) Cells and Increases the Activity of Rituximab and Venetoclax